Company Valuation: MEDICLIN AG

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 186.2 171 130.2 115 175.8 256.5 - -
Change - -8.16% -23.89% -11.68% 52.89% 45.95% - -
Enterprise Value (EV) 186.2 171 130.2 115 175.8 256.5 256.5 256.5
Change - -8.16% -23.89% -11.68% 52.89% 45.95% 0% 0%
P/E - - - - - - - -
PBR 1.02x 0.82x 0.66x 0.52x 0.71x 0.9x 0.8x 0.71x
PEG - - - - - - - -
Capitalization / Revenue 0.28x 0.24x 0.18x 0.15x 0.22x 0.33x 0.32x 0.31x
EV / Revenue 0x 0x 0x 0x 0x 0.33x 0.32x 0.31x
EV / EBITDA 0x 0x 0x 0x 0x 2.24x 2.23x 2.22x
EV / EBIT 0x 0x 0x 0x 0x 4.13x 4.11x 4.09x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Dividend per Share 2 - - - - 0.04 0.04 0.04 0.04
Rate of return - - - - 1.08% 0.74% 0.74% 0.74%
EPS 2 - - - - - - - -
Distribution rate - - - - - - - -
Net sales 1 673.1 704.7 730.1 748.8 784.5 787.5 803.2 819.3
EBITDA 1 85.22 90.92 98.73 103.8 115.6 114.3 115.3 115.6
EBIT 1 11.56 19.52 12.72 53.49 55.36 62.11 62.47 62.72
Net income 1 1.461 9.441 -10.78 24.84 25.49 36.66 38.2 40.12
Net Debt - - - - - - - -
Reference price 2 3.920 3.600 2.740 2.420 3.700 5.400 5.400 5.400
Nbr of stocks (in thousands) 47,500 47,500 47,500 47,500 47,500 47,500 - -
Announcement Date 3/30/22 3/31/23 3/27/24 3/28/25 3/27/26 - - -
1EUR in Million2EUR
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - 0.74% 292M
51.2x4.42x28.72x0.27% 13.27B
19.46x2.3x10.76x0.64% 12.23B
24.45x2.86x9.97x1.65% 10.85B
24.98x2.02x16.3x0.15% 10.19B
77.54x7.67x31.05x - 9.9B
19.45x2.83x11.66x4.12% 9.36B
31.04x1x7.88x1.98% 8.98B
14.26x1.36x7.96x1.88% 8.74B
108.89x13.99x72.94x-.--% 6.78B
Average 41.25x 4.27x 21.92x 1.27% 9.06B
Weighted average by Cap. 39.07x 3.95x 20.36x 1.29%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA



Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. MED Stock
  4. Valuation MEDICLIN AG